On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like 3 Hottest Areas of Drug Development to Keep an Eye on in 2018 December 19, 2017 SPR Therapeutics Promotes To SVP Of Research And Development September 6, 2017 Alnylam CEO Calls Out Trump's Alleged Immigration Remarks January 14, 2018
